Urinary glycosaminoglycan excretion in bladder carcinoma


Atahan Ö., Kayigil Ö., Hizel N., Yavuz Ö., Metin A.

Scandinavian Journal of Urology and Nephrology, cilt.30, sa.3, ss.173-177, 1996 (Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 3
  • Basım Tarihi: 1996
  • Doi Numarası: 10.3109/00365599609181295
  • Dergi Adı: Scandinavian Journal of Urology and Nephrology
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.173-177
  • Anahtar Kelimeler: Bladder carcinoma, Glycosaminoglycan
  • Ankara Yıldırım Beyazıt Üniversitesi Adresli: Hayır

Özet

The urinary glycosaminoglycan (GAG) excretion in 35 patients with bladder cancer was significantly greater than that in 30 normal persons. In the cancer patients, the results were analysed according to tumour characteristics. Statistically significant differences were found, with increased GAG levels paralleling tumour size, multifocality, stage and grade. These preliminary data suggest that, parallel with established clinical parameters, measurement of urinary GAG excretion provides an indicator of repair of the bladder epithelium.